Drug Delivery in the Reproductive Systems

Dear Colleagues,

The human reproductive system is a complex environment that is predisposed to a range of infections, physical injuries, physiological changes, autoimmune conditions and ailments. Reproductive system cancers; bacterial, fungal and viral infections; and hormonal fluctuations due to physiological changes or environmental causes have a significant impact on patient quality of life, with broader societal and economic effects. Extensive research into the causes and treatment of conditions involving the human reproductive system is needed to prevent and overcome these ailments. The aim of this Special Issue, therefore, is to showcase original research articles and reviews focusing on advanced drug delivery platforms for the treatment of conditions within the human reproductive system.

Research areas may include, but are not limited to, the following:

1. Novel synthesis of delivery systems, drug formulations, and development technologies for the treatment of conditions related to the human reproductive system;
2. Novel prophylactic treatment platforms for conditions related to the human reproductive system;
3. Targeting of specific cell populations or intracellular targeting in the human reproductive system environment;
4. Design of advanced targeted drug delivery devices for increased dosing accuracy and reproducibility;
5. Advanced drug delivery approaches for biopharmaceuticals including vaccines, antibiotics, nucleic acids, proteins and peptides.

We look forward to receiving your contributions.

Prof. Dr. Yahya E. Choonara
Dr. Mershen Govender
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.